Nexplanon 68 MG implants

Ended Awarded Last action

Contract number
SPE2DR26FLTP1
Awardee
Awarding agency
Obligated
$16,763

Award facts

Contract value 100% obligated
$16,762.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for Nexplanon 68 mg implants with a ceiling value of $16,762.80.

DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling authorized through December 31, 2036. Place of performance is Park Ridge, IL 60068. The order is priced firm fixed price with an ultimate completion date of March 11, 2026.

Quick answers

Who was awarded contract SPE2DR26FLTP1?

SPE2DR26FLTP1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 18, 2026.

How much is contract SPE2DR26FLTP1 worth?

The government has obligated $16,763 on SPE2DR26FLTP1.

Is contract SPE2DR26FLTP1 an order under another contract?

Yes. SPE2DR26FLTP1 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.

Was contract SPE2DR26FLTP1 competed?

The extent of competition for SPE2DR26FLTP1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award